Lymphoma Clinical Trials in Baltimore

Showing 141-160 of 633 trials

Resiliency in Older Adults Undergoing Bone Marrow Transplant

NCT04188678

The objective of this research is to measure certain indicators of resiliency to better understand which participants who are over 60 years old will respond more positively to bone marrow transplant. This research is being done to determine if there are traits that make recipients more likely to bounce back following allogeneic bone marrow transplant (BMT).

LeukemiaLymphomaBlood Cancer+3 more

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins126 participantsStarted Sep 2018

Baltimore, Maryland, United States

Active Not RecruitingPhase 3< 1 mile

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

NCT03057054

This randomized phase III trial studies how well Lactobacillus plantarum works in preventing acute graft versus host disease in children undergoing donor stem cell transplant. Lactobacillus plantarum may help prevent the development of gastrointestinal graft versus host disease in children, adolescents, and young adults undergoing donor stem cell transplant.

Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmLeukemia+1 more

Children's Oncology Group173 participantsStarted Apr 2018

Birmingham, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +40 more locations

Resiliency in Older Adults Undergoing Bone Marrow Transplant

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

Lymphoma Trials in Other Cities

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

EchoTip AcuCore Post-Market Clinical Study

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

Other Conditions in Baltimore